Scholars Central

ArticlePublished 30 May 2023

Development of upstream bioprocesses using vero cells to produce viral vectors and vaccines

Authors: Alex Quill

Pharmaceutical Bioprocessing

Volume 11 · Issue 3 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

For the purpose of creating viral vectors and vaccines, the Vero cell line is thought to be the most often employed continuous cell line. It is the first cell line in history to receive WHO approval for use in the creation of human vaccines. The literature contains extensive experimental data on the generation of several viruses utilising the Vero cell line. However, the micro-carrier technology is used in the vast majority of these procedures. Although this technology has been developed for the mass production of viral vaccines, it is still quite labor-intensive and complicated. Additionally, scale-up is still challenging and is constrained by the carriers’ provided surface area. It is crucial to continue to expand the Vero cell platform by utilising cutting-edge bioprocess technologies in order to get around these and other issues as well as to establish more effective manufacturing procedures. Advanced and scalable platform technologies could offer more effective and affordable ways to address the worldwide need for vaccines, particularly in situations like the present COVID-19 pandemic. In order to evaluate recent developments in bioprocess development, we analyse the current literature on Vero cell bioprocess development for the creation of viral vectors and vaccines in this article. By utilising recent advancements in the field of cell culture engineering, we critically highlight the necessity for additional research initiatives and outline obstacles to enhance the Vero cell platform [1-5].

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Bioprocessing.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Bioprocessing
  • SubjectPharmaceutical Sciences
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Alex Quill”